
Boston Scientific Corp. (B1SX34)
BOV
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.56 | 8.346 | 18.23 | -0.375 | 3.127 | 1.985 | 4.645 | 4.972 |
Return on Equity (%) | 1.513 | 21.235 | 41.587 | -0.788 | 6.166 | 3.755 | 8.463 | 8.923 |
Return on Invested Capital (%) | 10.209 | 21.756 | 57.509 | 4.75 | 10.405 | 9.559 | 12.765 | 13.858 |
Operating Margin (%) | 12.832 | 16.93 | 10.806 | 2.835 | 11.92 | 12.703 | 15.801 | 15.442 |
Net Profit Margin (%) | 1.149 | 17.011 | 43.782 | -1.16 | 8.286 | 5.062 | 11.025 | 11.065 |
Book Value Per Share | -4.24 | -4.013 | -3.238 | -0.527 | -0.942 | -0.912 | -0.603 | -1.193 |
Earnings Per Share | 0.076 | 1.207 | 3.369 | -0.08 | 0.58 | 0.445 | 1.064 | 1.249 |
Cash Per Share | 0.137 | 0.105 | 0.156 | 1.203 | 1.133 | 0.643 | 0.586 | 0.279 |
Working Capital Per Share | -1.334 | -0.909 | -0.12 | 2.09 | 1.203 | 1.356 | 1.072 | 0.351 |
Operating Profit Per Share | 4.903 | 5.277 | 5.686 | 4.703 | 5.02 | 6.276 | 7.033 | 8.021 |
EBIT Per Share | 0.679 | 1.027 | 0.493 | -0.055 | 0.633 | 0.79 | 1.346 | 1.537 |
EBITDA Per Share | 0.679 | 1.027 | 0.493 | -0.055 | 0.633 | 0.79 | 1.346 | 1.537 |
Free Cash Flow Per Share | -0.307 | 0.789 | 2.975 | -0.598 | 0.263 | 0.065 | 0.736 | 0.926 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 1,37B | 1,38B | 1,39B | N/A | 1,69B | 1,43B | N/A | N/A |
Fin d'année 31 Décembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | 15.049 | N/A | N/A | N/A | 17.583 | N/A | N/A | N/A |
Net Profit Margin (%) | 8.852 | N/A | N/A | N/A | 12.837 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 819,86B |
Ratio cours/bénéfice | 75,65 |
Ratio prix/ventes | 8,37 |
Ratio prix/liquidités | 338,63 |
Ratio prix/valeur comptable | 6,37 |
Rendement de dividende | - |
Actions en circulation | 1,47B |
Volume moyen (1 semaine) | 1,57k |
Volume moyen (1 mois) | 638 |
Variation sur 52 semaines | 57,24% |
Plus haut sur 52 semaines | 615,11 |
Plus bas sur 52 semaines | 350,70 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales